We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Appeals Court: Lyrica Generics Do Not Infringe Pfizer Patent
UK Appeals Court: Lyrica Generics Do Not Infringe Pfizer Patent
The UK Court of Appeal affirmed an earlier ruling that invalidates Pfizer’s patent claims for Lyrica, saying generic versions will not lead to any infringement.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor